A Form 4 filed on August 20, 2026 reports that Glenn P. Muir, a director of Cytek Biosciences, Inc. (NASDAQ:CTKB), acquired 3,086 shares of common stock on August 18, 2026 through the vesting of restricted stock units.
Wenbin Jiang, President and CEO of Cytek Biosciences, Inc. (NASDAQ:CTKB), filed a Form 4 on August 20, 2026, disclosing the vesting of restricted stock units and related tax-withholding share disposals on August 18, 2026.
A Statement of Changes in Beneficial Ownership was filed on August 20, 2026, disclosing a purchase of BorgWarner Inc. common stock by director Rajesh Kalathur on August 19, 2026.
Pablo J. Cagnoni, President and Global Head of R&D at Incyte Corp, filed a Form 4 on August 20, 2026, disclosing the sale of 10,801 shares of common stock on August 19, 2026, pursuant to a Rule 10b5-1 trading plan.
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corporation (NASDAQ:UTHR), filed a statement of changes in beneficial ownership on August 20, 2026, reporting the exercise of stock options and the sale of resulting common stock shares on August 19, 2026, pursuant to a …
Charles Lacey Compton III, CEO and Director of Fastly, Inc. (NASDAQ:FSLY), filed a Form 4 on August 20, 2026, reporting the sale of Class A Common Stock on August 18 and August 19, 2026.
Richard Wong, Chief Financial Officer of Fastly, Inc. (NASDAQ:FSLY), filed a Form 4 on August 20, 2026, disclosing the disposal of 148,015 shares of Class A Common Stock on August 18, 2026, to satisfy tax obligations connected to the vesting of previously granted Restricted …
Scott R. Lovett, President, Go to Market at Fastly, Inc. (NASDAQ:FSLY), filed a Form 4 on August 20, 2026, disclosing the sale of 14,936 shares of Class A Common Stock on August 18, 2026, to satisfy tax obligations arising from the vesting of previously …
A Form 4 filed on August 20, 2026, reports that Haiping Dun, a director of ACM Research, Inc. (NASDAQ:ACMR), exercised stock options and sold Class A Common Stock on August 18, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
A Form 4 filed on August 20, 2026 with the U.S. Securities and Exchange Commission discloses that Thimaya K. Subaiya, Executive Vice President of Operations at Cisco Systems, Inc. (NASDAQ:CSCO), sold a combined 5,832 shares of Cisco common stock on August 19, 2026 pursuant …